AVIRAtea Pharmaceuticals, Inc.May 12, 2026Q1 2026
Read transcript →Atea Pharmaceuticals, Inc. (AVIR) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$4.61
+2.11%
Mkt Cap $378.53M
AVIRAtea Pharmaceuticals, Inc.May 12, 2026AVIRAtea Pharmaceuticals, Inc.Mar 5, 2026Q4 2025
Read transcript →AVIRAtea Pharmaceuticals, Inc.Nov 12, 2025Q3 2025
Read transcript →AVIRAtea Pharmaceuticals, Inc.Aug 8, 2025Q2 2025
Read transcript →AVIRAtea Pharmaceuticals, Inc.Mar 6, 2025Q4 2024
Read transcript →AVIRAtea Pharmaceuticals, Inc.Nov 9, 2024Q3 2024
Read transcript →AVIRAtea Pharmaceuticals, Inc.Aug 11, 2024Q2 2024
Read transcript →AVIRAtea Pharmaceuticals, Inc.May 14, 2024Q1 2024
Read transcript →AVIRAtea Pharmaceuticals, Inc.Feb 28, 2024Q4 2023
Read transcript →AVIRAtea Pharmaceuticals, Inc.Nov 8, 2023Q3 2023
Read transcript →AVIRAtea Pharmaceuticals, Inc.Aug 8, 2023Q2 2023
Read transcript →AVIRAtea Pharmaceuticals, Inc.May 8, 2023Q1 2023
Read transcript →AVIRAtea Pharmaceuticals, Inc.Feb 28, 2023Q4 2022
Read transcript →AVIRAtea Pharmaceuticals, Inc.Nov 7, 2022Q3 2022
Read transcript →AVIRAtea Pharmaceuticals, Inc.Aug 8, 2022Q2 2022
Read transcript →AVIRAtea Pharmaceuticals, Inc.May 10, 2022Q1 2022
Read transcript →AVIRAtea Pharmaceuticals, Inc.Feb 28, 2022Q4 2021
Read transcript →AVIRAtea Pharmaceuticals, Inc.Nov 11, 2021Q3 2021
Read transcript →AVIRAtea Pharmaceuticals, Inc.Aug 12, 2021Q2 2021
Read transcript →AVIRAtea Pharmaceuticals, Inc.May 14, 2021Q1 2021
Read transcript →